Skip to main content
. 2011 May 2;29(17):2410–2415. doi: 10.1200/JCO.2011.34.7542

Fig 2.

Fig 2.

Acute myeloid leukemia (AML) survival in relation to previous therapy. Mixed combinations of two to three cytoreductive treatments (n = 46), alkylators only (n = 21), none (n = 47), hydroxyurea (HydroxyU) only (n = 45), and radioactive phosphorous (P32) only (n = 47).